SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016150
Filing Date
2022-08-09
Accepted
2022-08-09 17:02:19
Documents
78
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q crbp-20220630.htm   iXBRL 10-Q 2352258
2 EX-31.1 crbp-ex31_1.htm EX-31.1 20769
3 EX-31.2 crbp-ex31_2.htm EX-31.2 20946
4 EX-32.1 crbp-ex32_1.htm EX-32.1 12305
5 EX-32.2 crbp-ex32_2.htm EX-32.2 12183
  Complete submission text file 0000950170-22-016150.txt   9756053

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crbp-20220630_def.xml EX-101.DEF 210596
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crbp-20220630_cal.xml EX-101.CAL 62553
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbp-20220630.xsd EX-101.SCH 52744
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbp-20220630_pre.xml EX-101.PRE 391662
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbp-20220630_lab.xml EX-101.LAB 474196
72 EXTRACTED XBRL INSTANCE DOCUMENT crbp-20220630_htm.xml XML 2033154
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37348 | Film No.: 221149271
SIC: 2834 Pharmaceutical Preparations